Results 291 to 300 of about 500,057 (343)
Some of the next articles are maybe not open access.
Archives of Internal Medicine, 1972
To the Editor. —We read with interest the paper in the September issue1 on αheavy chain disease in which the pathological immunoglobulin disappeared with chemotherapy. The authors state that up to the time of acceptance of their paper all cases of so-called Mediterranean lymphoma and α-chain disease have occurred either in Arabs or oriental Jews in ...
S. Bank, B. H. Novis
openaire +3 more sources
To the Editor. —We read with interest the paper in the September issue1 on αheavy chain disease in which the pathological immunoglobulin disappeared with chemotherapy. The authors state that up to the time of acceptance of their paper all cases of so-called Mediterranean lymphoma and α-chain disease have occurred either in Arabs or oriental Jews in ...
S. Bank, B. H. Novis
openaire +3 more sources
Annals of the New York Academy of Sciences, 1971
The recent elucidation of the structure of immunoglobulins, and the more precise immunologic and chemical characterization of the proteins produced by patients with proliferative disorders of plasma cells and lymphocytes have led to a clearer understanding of the biosynthetic alterations accompanying them.
B. Frangione +2 more
openaire +3 more sources
The recent elucidation of the structure of immunoglobulins, and the more precise immunologic and chemical characterization of the proteins produced by patients with proliferative disorders of plasma cells and lymphocytes have led to a clearer understanding of the biosynthetic alterations accompanying them.
B. Frangione +2 more
openaire +3 more sources
Current Treatment Options in Oncology, 2002
The heavy chain diseases (HCDs) are rare B-cell malignancies that are distinguished by the production of a monoclonal immunoglobulin heavy chain (HC) without an associated light chain by the malignant B-cells. There are three types of HCD defined by the class of immunoglobulin (Ig) HC produced: IgA (alpha-HCD), IgG (gamma-HCD), and IgM (mu-HCD).
Thomas E. Witzig +1 more
openaire +3 more sources
The heavy chain diseases (HCDs) are rare B-cell malignancies that are distinguished by the production of a monoclonal immunoglobulin heavy chain (HC) without an associated light chain by the malignant B-cells. There are three types of HCD defined by the class of immunoglobulin (Ig) HC produced: IgA (alpha-HCD), IgG (gamma-HCD), and IgM (mu-HCD).
Thomas E. Witzig +1 more
openaire +3 more sources
Clinics in Laboratory Medicine, 1986
A review of alpha-heavy chain disease (AHCD) emphasizing its histopathology and associated lesions is presented. Unusual clinicopathologic presentations and modern concepts regarding histogenesis of AHCD in the light of recent immunohistochemical findings are discussed.
Parviz Haghighi, Paul L. Wolf
openaire +3 more sources
A review of alpha-heavy chain disease (AHCD) emphasizing its histopathology and associated lesions is presented. Unusual clinicopathologic presentations and modern concepts regarding histogenesis of AHCD in the light of recent immunohistochemical findings are discussed.
Parviz Haghighi, Paul L. Wolf
openaire +3 more sources
Structure of Abnormal Heavy Chains in Human Heavy-chain-deposition Disease
European Journal of Biochemistry, 1995The sequences of two immunoglobulin gamma 1 heavy chains involved in the formation of non-amyloid tissue deposits were determined in two patients (RIC and THR) affected with plasma cell monoclonal proliferation and heavy-chain-deposition disease. The proliferating plasma cells of patients RIC and THR synthesized truncated gamma 1 chains of 45 kDa and ...
Jean-Louis Preud'homme +3 more
openaire +2 more sources
Heavy chain deposition disease: The disease spectrum
American Journal of Kidney Diseases, 1999A 45-year-old white woman was found to have microscopic hematuria during her annual physical examination. After a negative urologic workup, she returned 5 months later with nephrotic syndrome, renal insufficiency, and hypocomplementemia. Renal biopsy showed a nodular sclerosing glomerulopathy that could not be further characterized because of ...
Morton Kleiner +5 more
openaire +2 more sources
La Ricerca in Clinica e in Laboratorio, 1976
Human heavy chain diseases offer an opportunity to examine the molecular events taking place in cells which produce naturally occurring structural variants of a well-studied complex protein. Extensive structural analyses have been carried out on many of these proteins and have revealed the existence of certain characteristic features.
Joel N. Buxbaum, Joel N. Buxbaum
openaire +2 more sources
Human heavy chain diseases offer an opportunity to examine the molecular events taking place in cells which produce naturally occurring structural variants of a well-studied complex protein. Extensive structural analyses have been carried out on many of these proteins and have revealed the existence of certain characteristic features.
Joel N. Buxbaum, Joel N. Buxbaum
openaire +2 more sources
1986
Heavy chain diseases (HCD) are immunoproliferative disorders characterized by the production of monoclonal immunoglobulin molecules composed of deleted heavy chains devoid of light chains. The diagnosis is established by immunoelectrophoresis (possibly combined to immunoselection) or immunofixation.
openaire +6 more sources
Heavy chain diseases (HCD) are immunoproliferative disorders characterized by the production of monoclonal immunoglobulin molecules composed of deleted heavy chains devoid of light chains. The diagnosis is established by immunoelectrophoresis (possibly combined to immunoselection) or immunofixation.
openaire +6 more sources
Gastric Alpha Heavy Chain Disease
Oncology, 1987Clinicopathological and immunohistological features of 4 cases of gastric lymphomas with alpha-heavy chain disease (AHCD) are described. Clinically there were no reliable features that could distinguish them from the 'western' types of gastric lymphomas (WGL).
Y.T. Omar, M.F. Tungekar, K. Behbehani
openaire +3 more sources
Diagnosis of Gamma Heavy-Chain Disease
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1981The diagnosis of gamma heavy-chain disease can be made only by immunochemical analysis of serum and urine. The case reported here demonstrates the importance of diligent observation of routine electrophoretic patterns, followed by immunoelectrophoresis where indicated for the identification of abnormal bands.
K R Hine +3 more
openaire +3 more sources